サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788234

オプティカルゲノムマッピングの世界市場

Optical Genome Mapping

出版日
ページ情報
英文 208 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
オプティカルゲノムマッピングの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 208 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

オプティカルゲノムマッピングの世界市場は2030年までに6億1,520万米ドルに達する見込み

2024年に1億3,960万米ドルと推定されるオプティカルゲノムマッピングの世界市場は、2030年には6億1,520万米ドルに達し、分析期間2024-2030年のCAGRは28.0％で成長すると予測されます。本レポートで分析したセグメントの1つであるオプティカルゲノムマッピングサービスは、CAGR 28.9％を記録し、分析期間終了時には3億3,260万米ドルに達すると予測されています。オプティカルゲノムマッピング消耗品・試薬セグメントの成長率は、分析期間中CAGR 29.8％と推定されます。

米国市場は3,670万米ドルと推定、中国はCAGR26.5％で成長予測

米国のオプティカルゲノムマッピング市場は、2024年には3,670万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR26.5％を引きずる形で、2030年までに9,290万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ25.7％と24.2％と予測されています。欧州では、ドイツがCAGR約19.3%で成長すると予測されています。

世界のオプティカルゲノムマッピング市場- 主要動向と促進要因のまとめ

なぜオプティカルゲノムマッピングは従来のゲノム解析を破壊するのか？

オプティカルゲノムマッピング（OGM）は、従来のシーケンス技術では見逃されがちな構造変異（SV）の同定において、これまでにない解像度と精度を提供し、ゲノム研究と診断において変革をもたらす存在として浮上しています。次世代シーケンサー（NGS）はゲノミクスに革命をもたらしたが、挿入、欠失、逆位、転座などの大規模なゲノム再配列の検出には依然として限界があります。超長鎖DNA分子を利用し、それをナノチャンネルアレイでイメージングすることにより、OGMは増幅や断片化をすることなく、ゲノム全体の構造的特徴をリアルタイムで可視化することができます。この能力は、複雑な遺伝性疾患、血液悪性腫瘍、固形腫瘍、希少疾患など、構造異常を理解することが診断や治療計画に不可欠な疾患において、特に有用であることが分かってきています。個別化医療における包括的なゲノム・プロファイリングの必要性の高まりは、費用対効果が高く拡張性のあるソリューションへの要求と相まって、学術機関、臨床検査室、バイオテクノロジー企業を、OGMを補完的、あるいは主要なツールとして採用するよう促しています。既存のバイオインフォマティクスパイプラインとシームレスに統合できる一方で、シーケンシングだけでは得られない知見を提供できるOGMは、研究ワークフローを再構築し、トランスレーショナルアプリケーションや臨床アプリケーションにおけるゲノムデータの有用性を拡大しています。

技術の進歩はOGMの性能とアクセシビリティをどのように向上させているか？

オプティカルゲノムマッピングの状況は、OGMのプラットフォームをより強固に、より使いやすく、より広範なアプリケーションで利用しやすくする重要な技術的進歩によって急速に変化しています。ナノチャンネルチップの設計とサンプル調製の自動化における改良は、作業時間を短縮し、スループットを向上させ、OGMを大量の臨床ラボと学術研究センターの両方にとってより実用的なものにしています。AIと機械学習アルゴリズムの統合は、構造バリアントのコールと解釈の精度を高め、人的エラーを最小限に抑え、より信頼性の高い診断を可能にしています。同時に、データ解析のためのクラウドベースのプラットフォームは、研究者と臨床医とのコラボレーションを簡素化し、ゲノムの知見への安全でリアルタイムなアクセスを可能にしています。OGMプラットフォームを分散型やポイントオブケア環境に適したものにすることを目標に、小型化と可搬化の取り組みも進行中です。血液、骨髄、固形組織など様々な種類のサンプルから、複雑な処理なしに超高分子量DNAを分析できるようになったことで、この方法の有用性が拡大しています。さらに、蛍光標識化学と光学検出の進歩により、シグナルの鮮明度が向上し、大規模ゲノムにわたる構造要素をより正確にマッピングできるようになっています。このような技術革新が進むにつれ、導入の障壁が低くなるだけでなく、ゲノム解析のスピード、スケーラビリティ、感度の新たな基準が確立されつつあります。

どのような最終用途部門が需要を牽引し、アプリケーションのフロンティアを広げていますか？

オプティカルゲノムマッピングの需要は、多様なエンドユース分野で加速しており、それぞれが異なるが重複する目的でこの技術を活用しています。臨床診断では、血液学と腫瘍学が最も活発な領域であり、OGMは白血病、リンパ腫、固形腫瘍に関連する構造変異を発見するために使用されています。生殖遺伝学では、OGMは、異数体やコピー数変異のような染色体異常の出生前および出生後の診断に利用されつつあります。学術研究機関やゲノムセンターも、複雑なゲノム構造や遺伝子制御ネットワークを明らかにする能力から、集団調査、進化生物学、機能ゲノミクスにOGMを採用しています。バイオ医薬品分野では、OGMは創薬パイプラインに組み込まれつつあり、特にバイオマーカーの同定や、人工細胞株における遺伝的不安定性の特徴付けに利用されています。農業ゲノミクスもまた新たな分野であり、OGMは作物改良や形質選択のために植物ゲノムのマッピングに利用されています。このように使用事例が広範に拡大しているため、さまざまなサンプルタイプやデータ解析環境に対応できる汎用性の高いOGMプラットフォームへの需要が高まっています。さらに、テクノロジープロバイダーとヘルスケア機関のコラボレーションが、検証研究と臨床採用を促進し、市場を広く受け入れられる方向へと押し上げています。

オプティカルゲノムマッピング市場成長の原動力は？

オプティカルゲノムマッピング市場の成長は、技術の進化、エンドユーザーの需要、ゲノム研究と診断の優先順位のシフトに関連するいくつかの要因によってもたらされます。特に腫瘍学や希少疾患の診断において、高分解能の構造変異検出の必要性が高まっており、検査室がOGMをワークフローに組み込むことを後押ししています。大規模なゲノム変化の同定におけるショートリードシーケンスの限界は、特に包括的なゲノム構造プロファイリングが不可欠な場合に、OGMに対する補完的な需要を生み出しています。自動化装置、改良されたナノチャンネルアレイ設計、およびスケーラブルなデータ解析プラットフォームにおける進歩は、OGMをより使いやすく、運用上効率的なものにしています。ゲノム医療とプレシジョン・オンコロジーに対する資金提供の増加、特に政府や民間の医療イニシアティブによる資金提供の増加により、病院や専門ラボの顧客基盤が拡大しています。OGMとマルチオミクスアプローチおよびバイオインフォマティクスエコシステムとの統合は、研究および臨床の両領域において、エンドツーエンドでシステムレベルの洞察を得る機会を生み出しています。これまで診断不可能であった症例を解決するOGMのユニークな価値に対する臨床医や遺伝学者の意識の高まりが、採用を加速しています。新興市場では、希少疾患の発見と費用対効果の高いがん診断の改善を求める動きが、非シークエンシングベースのゲノムツールへの投資を促しています。これらの累積的な推進力により、オプティカルゲノムマッピングは精密診断とゲノム発見の次の時代における重要なイネーブラーとして確立されつつあります。

セグメント

製品タイプ（オプティカルゲノムマッピングサービス、オプティカルゲノムマッピング消耗品・試薬、オプティカルゲノムマッピングソフトウェア、オプティカルゲノムマッピング機器）、技術タイプ（構造変異検出、ゲノム会議場、微生物株タイピング、その他の技術）、用途（研究、診断）、最終用途（学術研究機関、病院・臨床研究所、バイオテクノロジー・製薬企業）

調査対象企業の例

  • Agilent Technologies Inc.
  • Bionano Genomics
  • Bio-Rad Laboratories Inc.
  • Cerba Research
  • Genohub Inc.
  • Hamilton Company
  • Hofkens Lab
  • Illumina Inc.
  • INRAE（French Plant Genomic Resources Center）
  • MedGenome
  • Nabsys
  • NanoString Technologies
  • Nucleome Informatics
  • OpGen
  • Oxford Nanopore Technologies
  • PacBio（Pacific Biosciences）
  • PerkinElmer Genomics
  • Praxis Genomics, LLC
  • QIAGEN N.V.
  • Source BioScience

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32436

Global Optical Genome Mapping Market to Reach US$615.2 Million by 2030

The global market for Optical Genome Mapping estimated at US$139.6 Million in the year 2024, is expected to reach US$615.2 Million by 2030, growing at a CAGR of 28.0% over the analysis period 2024-2030. Optical Genome Mapping Services, one of the segments analyzed in the report, is expected to record a 28.9% CAGR and reach US$332.6 Million by the end of the analysis period. Growth in the Optical Genome Mapping Consumables & Reagents segment is estimated at 29.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$36.7 Million While China is Forecast to Grow at 26.5% CAGR

The Optical Genome Mapping market in the U.S. is estimated at US$36.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$92.9 Million by the year 2030 trailing a CAGR of 26.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.7% and 24.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.3% CAGR.

Global Optical Genome Mapping Market - Key Trends & Drivers Summarized

Why Is Optical Genome Mapping Disrupting Conventional Genomic Analysis?

Optical Genome Mapping (OGM) is emerging as a transformative force in genomic research and diagnostics, offering unprecedented resolution and accuracy in identifying structural variations (SVs) that are often missed by traditional sequencing technologies. While next-generation sequencing (NGS) has revolutionized genomics, it remains limited in detecting large-scale genomic rearrangements such as insertions, deletions, inversions, and translocations-areas where OGM excels. By utilizing ultra-long DNA molecules and imaging them in nanochannel arrays, OGM allows for real-time visualization of structural features across the entire genome without amplification or fragmentation. This capability is proving especially valuable in complex genetic disorders, hematological malignancies, solid tumors, and rare diseases, where understanding structural anomalies is critical for diagnosis and treatment planning. The growing need for comprehensive genomic profiling in personalized medicine, coupled with the demand for cost-effective and scalable solutions, is pushing academic institutions, clinical laboratories, and biotech companies to adopt OGM as a complementary or even primary tool. Its ability to integrate seamlessly with existing bioinformatics pipelines while offering insights that sequencing alone cannot provide is reshaping research workflows and expanding the utility of genomic data in translational and clinical applications.

How Are Technological Advances Enhancing the Performance and Accessibility of OGM?

The Optical Genome Mapping landscape is being rapidly reshaped by significant technological advancements that are making the platform more robust, user-friendly, and accessible across a broader range of applications. Improvements in nanochannel chip design and automated sample preparation are reducing hands-on time and increasing throughput, making OGM more practical for both high-volume clinical labs and academic research centers. The integration of AI and machine learning algorithms is enhancing the accuracy of structural variant calling and interpretation, minimizing human error and allowing for more reliable diagnostics. At the same time, cloud-based platforms for data analysis are simplifying collaboration between researchers and clinicians, enabling secure, real-time access to genomic insights. Miniaturization and portability efforts are also underway, with the goal of making OGM platforms suitable for decentralized and point-of-care environments. The ability to analyze ultra-high molecular weight DNA from various sample types-blood, bone marrow, solid tissue-without complex processing is expanding the method’s utility. Moreover, advancements in fluorescent labeling chemistries and optical detection are improving signal clarity, allowing for more precise mapping of structural elements across large genomes. As these innovations continue, they are not only lowering the barriers to adoption but also setting new standards in speed, scalability, and sensitivity for genomic analysis.

What End-Use Sectors Are Driving Demand and Expanding Application Frontiers?

The demand for Optical Genome Mapping is accelerating across a diverse set of end-use sectors, each leveraging the technology for distinct yet overlapping purposes. In clinical diagnostics, hematology and oncology are the most active domains, with OGM being used to uncover structural variants associated with leukemias, lymphomas, and solid tumors-many of which are undetectable through conventional karyotyping or chromosomal microarrays. In reproductive genetics, OGM is gaining traction for pre- and post-natal diagnostics of chromosomal abnormalities such as aneuploidies and copy number variations. Academic research institutions and genome centers are also adopting OGM for population studies, evolutionary biology, and functional genomics, due to its ability to uncover complex genomic architectures and gene regulatory networks. In the biopharmaceutical sector, OGM is being integrated into drug discovery pipelines, especially in biomarker identification and characterization of genetic instability in engineered cell lines. Agricultural genomics is another emerging area, where OGM is used to map plant genomes for crop improvement and trait selection. These broad and expanding use cases are driving demand for versatile OGM platforms that can operate across different sample types and data analysis environments. Furthermore, collaborations between technology providers and healthcare institutions are catalyzing validation studies and clinical adoption, pushing the market toward widespread acceptance.

What Forces Are Powering the Growth of the Optical Genome Mapping Market?

The growth in the Optical Genome Mapping market is driven by several factors related to technological evolution, end-user demands, and shifts in genomic research and diagnostic priorities. The growing need for high-resolution structural variant detection, particularly in oncology and rare disease diagnostics, is pushing laboratories to integrate OGM into their workflows. The limitations of short-read sequencing in identifying large-scale genomic alterations are creating a complementary demand for OGM, especially in cases where comprehensive genome structural profiling is essential. Advancements in automated instrumentation, improved nanochannel array designs, and scalable data analysis platforms are making OGM more user-friendly and operationally efficient. Increasing funding for genomic medicine and precision oncology, especially from government and private healthcare initiatives, is expanding the customer base among hospitals and specialty labs. The integration of OGM with multi-omics approaches and bioinformatics ecosystems is creating opportunities for end-to-end, systems-level insights in both research and clinical domains. Rising awareness among clinicians and geneticists about the unique value of OGM in solving previously undiagnosable cases is accelerating adoption. In emerging markets, the push for improved rare disease detection and cost-effective cancer diagnostics is encouraging investment in non-sequencing-based genomic tools. These cumulative drivers are establishing Optical Genome Mapping as a critical enabler in the next era of precision diagnostics and genomic discovery.

SCOPE OF STUDY:

The report analyzes the Optical Genome Mapping market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software, Optical Genome Mapping Instruments); Technique (Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique, Other Techniques); Application (Research Application, Diagnostics Application); End-Use (Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use, Biotechnology & Pharmaceutical Companies End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies Inc.
  • Bionano Genomics
  • Bio-Rad Laboratories Inc.
  • Cerba Research
  • Genohub Inc.
  • Hamilton Company
  • Hofkens Lab
  • Illumina Inc.
  • INRAE (French Plant Genomic Resources Center)
  • MedGenome
  • Nabsys
  • NanoString Technologies
  • Nucleome Informatics
  • OpGen
  • Oxford Nanopore Technologies
  • PacBio (Pacific Biosciences)
  • PerkinElmer Genomics
  • Praxis Genomics, LLC
  • QIAGEN N.V.
  • Source BioScience

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Optical Genome Mapping - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Limitations of Traditional Sequencing Technologies Throw the Spotlight on Structural Variant Detection Through Optical Genome Mapping (OGM)
    • Surge in Rare Disease and Oncology Research Spurs Growth in High-Resolution, Non-Sequencing-Based Genomic Tools
    • Clinical Demand for Comprehensive Genomic Profiling Expands Addressable Market Opportunity for OGM Platforms
    • Integration with Multi-Omics and Bioinformatics Pipelines Strengthens the Business Case for Complementary Use of OGM
    • Advancements in AI-Powered Structural Variant Interpretation Drive Adoption in Clinical and Translational Research
    • Increased Focus on Personalized Medicine Accelerates Demand for Genome-Wide, High-Fidelity Mapping Technologies
    • Automation of Sample Prep and Nanochannel Imaging Enhances Throughput and Enables Scalability in High-Volume Labs
    • Rising Application in Prenatal, Pediatric, and Reproductive Health Creates New Use Cases for OGM in Cytogenetics
    • Adoption in Cell and Gene Therapy Research Fuels Demand for Structural Integrity Mapping in Engineered Cell Lines
    • Global Expansion of Genomic Medicine Programs Sustains Growth in Emerging Markets With Unmet Diagnostic Needs
    • Technological Innovation in DNA Labeling and Imaging Systems Drives Performance Enhancements in Mapping Accuracy
    • Growing Recognition of OGM as a Complement to Short- and Long-Read Sequencing Encourages Platform Convergence
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Optical Genome Mapping Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Optical Genome Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Optical Genome Mapping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Optical Genome Mapping Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Optical Genome Mapping Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Optical Genome Mapping Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Optical Genome Mapping Consumables & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Optical Genome Mapping Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Optical Genome Mapping Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Optical Genome Mapping Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Optical Genome Mapping Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Hospitals & Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Hospitals & Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biotechnology & Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Biotechnology & Pharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Structural Variant Detection Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Structural Variant Detection Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Genome Assembly Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Genome Assembly Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Microbial Strain Typing Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Microbial Strain Typing Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • JAPAN
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • CHINA
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 54: China Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • EUROPE
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Optical Genome Mapping by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • FRANCE
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 72: France Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • GERMANY
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • UNITED KINGDOM
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 96: UK Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030

IV. COMPETITION